LYNPARZA (AstraZeneca)
(https://lynparza.com) 📸 Data Snapshot: May 31, 2026Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
While the site claims Nicole is a real patient, there is no outbound link or verification path to her actual case study or external testimonials. The review_count of 1 or 2 in the schema data is likely an internal metadata artifact rather than verified consumer reviews. However, the presence of specific support lines (1-800-770-8337) and Access 360 program details adds a layer of operational substance over pure theatre.
The ratio of evidence to fluff is high; nearly every paragraph contains a specific medical condition, genetic marker, or duration of treatment (e.g., 16 weeks of first treatment). The proof is primarily internal (Prescribing Information), which is standard for the industry. Specific proof points like the exact temperature juice to avoid (Seville oranges) demonstrate a high attention to technical detail over vague assertions.
Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.
🛡️ Trust Signals — reviews, proof links, trust-theatre check
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 1 | 1 |
| /ovarian-cancer/home.html | 1 | 1 |
| /patient-support.html | 1 | 1 |
| /patient-support/my-lynparza-support-program.html | 2 | 1 |
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
Homepage schema
[
{
"@context": "https://schema.org/",
"url": "https://www.lynparza.com/",
"@type": "MedicalWebPage",
"name": "LYNPARZA",
"description": "Discover LYNPARZA—an oral, non-chemotherapy medication that may give you and your doctor a different option in the treatment of certain types of cancer."
},
{
"@context": "https://schema.org/",
"url": "https://www.lynparza.com/",
"@type": "MedicalAudience",
"audienceType": "Patient",
"geographicArea": "For US consumers"
},
{
"@context": "https://schema.org/",
"url": "https://www.lynparza.com/",
"@type": "Website",
"name": "Lynparza.com"
}
]
/ovarian-cancer/home.html
[
{
"@context": "https://schema.org/",
"url": "https://www.lynparza.com/ovarian-cancer/home.html",
"@type": "MedicalWebPage",
"name": "Talk to your doctor about LYNPARZA for certain types of advanced or recurrent ovarian cancer.",
"description": "LYNPARZA is used as a maintenance therapy and can be taken alone or in combination with the medicine bevacizumab. Maintenance therapy is a treatment used after initial therapy has ended. It can help extend the time without cancer growing or returning."
},
{
"@context": "https://schema.org/",
"url": "https://www.lynparza.com/ovarian-cancer/home.html",
"@type": "MedicalAudience",
"audienceType": "Patient",
"geographicArea": "For US consumers"
}
]
/patient-support.html
[
{
"@context": "https://schema.org/",
"url": "https://www.lynparza.com/patient-support.html",
"@type": "MedicalWebPage",
"name": "Patient support",
"description": "Access resources that are designed to guide and support you during your treatment with LYNPARZA."
},
{
"@context": "https://schema.org/",
"url": "https://www.lynparza.com/patient-support.html",
"@type": "MedicalAudience",
"audienceType": "Patient",
"geographicArea": "For US consumers"
}
]
/patient-support/my-lynparza-support-program.html
[
{
"@context": "https://schema.org/",
"url": "https://www.lynparza.com/patient-support/my-lynparza-support-program.html",
"@type": "MedicalWebPage",
"name": "Education and support are available through MyLYNPARZA",
"description": "AstraZeneca developed this support program to be there for you and your loved ones during treatment with LYNPARZA. By signing up, you will receive advice and information about treatment"
},
{
"@context": "https://schema.org/",
"url": "https://www.lynparza.com/patient-support/my-lynparza-support-program.html",
"@type": "MedicalAudience",
"audienceType": "Patient",
"geographicArea": "For US consumers"
}
]
This page presents a snapshot of public data from LYNPARZA (AstraZeneca), captured on May 31, 2026, to show how machine logic reads Trust & Proof signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to LYNPARZA (AstraZeneca): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://lynparza.com to view the most current version of its content and see directly what this company is about and what it offers.